BioCentury
ARTICLE | Clinical News

Naturaferon interferon alfa-n3 regulatory update

January 30, 2012 8:00 AM UTC

Hemispherx Biopharma said Argentina approved a regulatory application from marketing partner GP Pharm for Naturaferon interferon alfa-n3 to treat genital warts. GP Pharm, part of Lipotec S.A. (Gava, ...